Set Your Sights On Viking Therapeutics Inc (NASDAQ: VKTX)’S Upside Potential

Viking Therapeutics Inc (VKTX) concluded trading on Wednesday at a closing price of $27.09, with 4.16 million shares of worth about $112.81 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -34.71% during that period and on June 25, 2025 the price saw a […]

Viking Therapeutics Inc (VKTX): Street Finally Waking Up

Currently, there are 112.29M common shares owned by the public and among those 108.99M shares have been available to trade. The company’s stock has a 5-day price change of 9.65% and -18.59% over the past three months. VKTX shares are trading -30.57% year to date (YTD), with the 12-month market performance down to -59.42% lower. […]

Is Viking Therapeutics Inc (NASDAQ: VKTX) Proving The Doubters Wrong?

Viking Therapeutics Inc (VKTX) concluded trading on Wednesday at a closing price of $25.79, with 4.18 million shares of worth about $107.87 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -60.81% during that period and on April 23, 2025 the price saw a […]

Viking Therapeutics Inc (NASDAQ: VKTX) – Not A Clear Buying Opportunity?

Viking Therapeutics Inc (VKTX) concluded trading on Wednesday at a closing price of $32.23, with 4.47 million shares of worth about $143.99 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 117.62% during that period and on Wednesday the price saw a gain of […]

Viking Therapeutics Inc (NASDAQ: VKTX): Do Not Miss The Gain Train

Viking Therapeutics Inc (VKTX) concluded trading on Thursday at a closing price of $28.89, with 8.49 million shares of worth about $245.21 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 98.01% during that period and on Thursday the price saw a gain of […]

Viking Therapeutics Inc (NASDAQ: VKTX): Hunting Genuine Value In Market Debris

Fidelity Management & Research Co recently announced the acquisition of new stake in Viking Therapeutics Inc (NASDAQ:VKTX). The institutional investor has increased its shareholding in the Healthcare company by 0.19% to 14.94 million shares with purchase of 28523.0 shares. This fresh investment now brings its stake to 14.94% valued currently at $182.58 million. In addition, […]

Viking Therapeutics Inc (NASDAQ: VKTX): Analyst View Points To Future Growth

Fidelity Management & Research Co has recently announced that it has increased stake in Viking Therapeutics Inc (NASDAQ:VKTX) by 0.19%. After grabbing 14.94 million shares, the institutional investor is now in possession of 28523.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.94% having worth around $182.58 million. […]

Viking Therapeutics Inc (NASDAQ: VKTX) – Not A Clear Buying Opportunity?

Fidelity Management & Research Co has recently announced that it has increased stake in Viking Therapeutics Inc (NASDAQ:VKTX) by 0.19%. After grabbing 14.94 million shares, the institutional investor is now in possession of 28523.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.94% having worth around $146.57 million. […]

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.